REPH实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (22 Mar 2022 @ 12:00):

Stats
今日成交量	137 536
平均成交量	128 488
市值	177.42M
EPS	$-0.0000600 ( 2023-03-30 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-8.04
ATR14	$0.0920 (4.40%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-02	Lake Ryan David	Sell	1 419	Common Stock
2023-12-15	Lake Ryan David	Sell	5 690	Common Stock
2023-11-30	Lake Ryan David	Sell	1 197	Common Stock
2023-10-31	Lake Ryan David	Sell	1 198	Common Stock
2023-09-30	Lake Ryan David	Sell	1 198	Common Stock

INSIDER POWER
94.69
Last 95 transactions
Buy: 16 300 004 \| Sell: 826 395

音量相关性

長: -0.07 (neutral)

短: 0.64 (weak)

Signal:(67.783) Neutral

Recro Pharma Inc 相关性

10 最正相关
CNDT	0.875
EGBN	0.874
ANNX	0.87
FEYE	0.863
CYXT	0.863
FNWB	0.861
DCOMP	0.858
FFWM	0.852
ATHA	0.846
BWBBP	0.843

10 最负相关
NRDS	-0.898
SGTX	-0.876
NVTS	-0.859
PESI	-0.851
MORF	-0.848
WVVI	-0.844
BTBD	-0.839
FTIV	-0.837
INOD	-0.836
AMRB	-0.835

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Recro Pharma Inc 相关性 - 货币/商品

0.43
( neutral )

0.42
( neutral )

0.00
( neutral )

0.50
( neutral )

0.18
( neutral )

-0.50
( neutral )

Recro Pharma Inc 财务报表

Annual	2023
营收:	$94.64M
毛利润:	$18.14M (19.17 %)
EPS:	$-0.000100

FY	2023
营收:	$94.64M
毛利润:	$18.14M (19.17 %)
EPS:	$-0.000100

FY	2022
营收:	$90.21M
毛利润:	$23.14M (25.65 %)
EPS:	$-0.340

FY	2021
营收:	$75.36M
毛利润:	$19.82M (26.30 %)
EPS:	$-0.221

Financial Reports:

No articles found.

Recro Pharma Inc

Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It offers its products in the form of oral solid doses, sterile injectables, oral liquids, tablets, topicals, liquid/powder filled capsules, ophthalmic droppers, liposomes, and nano/microparticles, as well as in the areas of aseptic fill/finish, lyophilization, packaging, and logistics services. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.